AbbVie (ABBV) Surpasses Q3 Earnings and Revenue Estimates

Oct 30, 2024 · AbbVie (ABBV) delivered earnings and revenue surprises of 2.74% and 1.29%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies …

CouponFollow Extension

74%
OFF

AbbVie (ABBV) Surpasses Q3 Earnings And Revenue Estimates

1 week from now

Oct 30, 2024 · AbbVie (ABBV) delivered earnings and revenue surprises of 2.74% and 1.29%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies …

yahoo.com

15%
OFF

AbbVie (ABBV) Q3 Earnings And Revenues Beat Estimates - Yahoo …

1 week from now

Oct 27, 2023 · AbbVie (ABBV) delivered earnings and revenue surprises of 3.15% and 1.65%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies …

yahoo.com

$3.00
OFF

AbbVie Trumps Q3 Earnings & Sales Estimates, Raises '24 EPS View

1 week from now

Oct 30, 2024 · In This Article: ABBV. AbbVie Inc. ABBV reported adjusted earnings of $3.00 per share for the third quarter of 2024, beating the Zacks Consensus Estimate of $2.92. The reported earnings also ...

yahoo.com

15%
OFF

AbbVie (ABBV) Q3 Earnings And Revenues Beat Estimates

1 week from now

Oct 27, 2023 · AbbVie (ABBV) delivered earnings and revenue surprises of 3.15% and 1.65%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies …

zacks.com

$1.00
OFF

AbbVie Reports Third-Quarter 2023 Financial Results | AbbVie

1 week from now

Oct 27, 2023 · Reports Third-Quarter Diluted EPS of $1.00 on a GAAP Basis, a Decrease of 54.8 Percent; Adjusted Diluted EPS of $2.95, a Decrease of 19.4 Percent; These Results Include …

abbvie.com

8%
OFF

AbbVie (ABBV) Earnings Date And Reports 2024 - MarketBeat

1 week from now

4 days ago · AbbVie announced Q3 2024 earnings on October 30, 2024, reporting an EPS of $3.00, which beat the consensus estimate of $2.92 by $0.08. Quarterly revenue rose 3.8% …

marketbeat.com

8%
OFF

Compared To Estimates, AbbVie (ABBV) Q3 Earnings: A Look At

1 week from now

Oct 30, 2024 · For the quarter ended September 2024, AbbVie (ABBV) reported revenue of $14.46 billion, up 3.8% over the same period last year. EPS came in at $3.00, compared to …

nasdaq.com

6%
OFF

Compared To Estimates, AbbVie (ABBV) Q3 Earnings: A Look At Key …

1 week from now

Oct 27, 2023 · For the quarter ended September 2023, AbbVie (ABBV) reported revenue of $13.93 billion, down 6% over the same period last year. EPS came in at $2.95, compared to …

yahoo.com

$3.00
OFF

AbbVie Tops Q3 Expectations As Skyrizi, Rinvoq Drive Growth

1 week from now

Oct 30, 2024 · AbbVie's Q3 earnings surpassed expectations with $3.00 EPS and $14.46 billion in revenue. Skyrizi and Rinvoq led growth; AbbVie also raised 2024 EPS guidance.

benzinga.com

8%
OFF

AbbVie Inc (ABBV) Q3 2024 Earnings: Revenue Beats At $14.46B, …

1 week from now

Oct 30, 2024 · Financial Performance Overview. AbbVie Inc (ABBV, Financial) reported third-quarter net revenues of $14.460 billion, surpassing the analyst estimate of $14.277 billion. This marks a 3.8% increase on a reported basis and a 4.9% increase on an operational basis. However, the company's GAAP diluted EPS was $0.88, a 12% decrease from the previous ...

gurufocus.com

$10.67
OFF

AbbVie Reports Third-Quarter 2024 Financial Results - PR Newswire

1 week from now

Oct 30, 2024 · Full-Year 2024 Outlook. AbbVie is raising its adjusted diluted EPS guidance for the full year 2024 from $10.67 - $10.87 to $10.90 - $10.94, which includes an unfavorable impact …

prnewswire.com

$2.95
OFF

AbbVie (ABBV) Q3 Earnings And Revenues Beat Estimates

1 week from now

Oct 27, 2023 · AbbVie (ABBV) came out with quarterly earnings of $2.95 per share, beating the Zacks Consensus Estimate of $2.86 per share. This compares to earnings of $3.66 per share …

nasdaq.com

$56
OFF

AbbVie: Strong Financial Performance And Optimistic Outlook With …

1 week from now

Oct 30, 2024 · ABBV Earnings: AbbVie Reports Strong Q3 Results, Raises Outlook AbbVie raises FY24 revenue view to ~$56B from ~$55.5B, consensus $55.73B AbbVie sees Q4 adjusted …

businessinsider.com

6%
OFF

AbbVie Inc. ($ABBV) Stock Forecast - Morpher

1 week from now

Oct 31, 2024 · 30.09.2024 - ABBV Stock was up 2.6%. AbbVie reported third-quarter earnings that exceeded expectations, with adjusted EPS of $3.00 and net revenues of $14.46 billion, …

morpher.com

$2.95
OFF

AbbVie Lowers Q3 And FY24 Earnings Estimates Amid Higher R&D …

1 week from now

Oct 4, 2024 · AbbVie is set to release its Q3 FY24 results on October 30. The Street expects AbbVie to post adjusted earnings per share of $2.95 on revenue of $14.27 billion. According to …

nasdaq.com

FAQs about AbbVie (ABBV) Surpasses Q3 Earnings and Revenue Estimates Coupon?

How did AbbVie (abbv) perform in the quarter ended September 2023?

AbbVie (ABBV) delivered earnings and revenue surprises of 3.15% and 1.65%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock? ...

What is the consensus EPS estimate for AbbVie (abbv)?

The current consensus EPS estimate is $2.99 on $14.8 billion in revenues for the coming quarter and $10.85 on $55.85 billion in revenues for the current fiscal year. AbbVie (ABBV) delivered earnings and revenue surprises of 2.74% and 1.29%, respectively, for the quarter ended September 2024. ...

How did AbbVie perform compared to consensus earnings estimates?

The company provided EPS guidance of 2.940-2.980 for the period, compared to the consensus earnings per share estimate of 2.950. The company issued revenue guidance of $14.8 billion-$14.8 billion, compared to the consensus revenue estimate of $14.6 billion. Did AbbVie beat their earnings estimates last quarter? ...

How much money does AbbVie make a year?

AbbVie (NYSE:ABBV) has a recorded annual revenue of $54.32 billion. How much profit does AbbVie generate each year? AbbVie (NYSE:ABBV) has a recorded net income of $4.86 billion. ABBV has generated $2.88 earnings per share over the last four quarters. ...

Why did AbbVie deliver a quarter of outstanding results?

"We delivered another quarter of outstanding results driven by accelerating performance across our non-Humira growth platform, which is demonstrating double-digit growth," said Richard A. Gonzalez, chairman and chief executive officer, AbbVie. ...

How much will AbbVie's earnings increase in Q3?

AbbVie's earnings are expected to grow from $10.97 per share to $12.15 per share in the next year, which is a 10.76% increase. Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? ...